VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹45 Cr | ₹28 Cr | ₹27 Cr | ₹41 Cr | ₹62 Cr |
What is the latest Consolidated Net Profit of VENUS REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹28 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹62 Cr |
How is Consolidated Net Profit of VENUS REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | 59.05 | |
| Mar2024 | ₹28 Cr | 7.25 | |
| Mar2023 | ₹27 Cr | -34.77 | |
| Mar2022 | ₹41 Cr | -34.07 | |
| Mar2021 | ₹62 Cr | - | |
Compare Consolidated Net Profit of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,103.0 Cr | 7.8% | 45.7% | 144.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| CIPLA | ₹122,555.0 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 7.8% |
45.7% |
144.7% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses